Drug Trial Radar · NCT07556393
Environmental Exposure Unit Trial in Subjects With Ragweed-induced Allergic Rhinitis
Last checked: Nov 19, 2026Latest source record: Apr 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
78
Actual
Start
Jan 19, 2026
Primary completion
Apr 23, 2026
Study completion Apr 23, 2026
Sponsor
- Lead sponsor
- Inimmune CorporationIndustry
- Sponsor type
- Industry
- Collaborators
- Rho, Inc.
- First posted
- Apr 29, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this trial is to see how well an experimental nasal spray, called INI-2004, works for those with allergy symptoms to ragweed. This nasal spray will compare how well 500mcg of INI-2004, given once per week for 4 weeks, works at reducing ragweed allergy symptoms in an Environmental Exposure Unit (EEU), compared to placebo.
Conditions
- Allergic Rhinitis Due to Allergens
- Rhinitis Allergic
- Allergic Rhinitis
Interventions
INI-2004Drug
Toll-like receptor \[TLR\]4 agonist liposomal formulation
PlaceboOther
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of incidence, severity and relationship of treatment-emergent adverse events (TEAEs), leading to discontinuation of study treatmentTime frame: Baseline (SV2) vs Day 24
- Calculate the change from baseline (SV2) vs D24 in Total Nasal Symptom Score (TNSS) during the chamber exposure (AUC0-180) for all subjectsTime frame: Baseline (SV2) vs Day 24
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Kingston Health Sciences Centre- KGH site
Kingston, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.